Rheumatoid Arthritis Patients at Risk for Lung Disease
Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
Recruiting
Observational Study
Rheumatoid Arthritis
Interstitial Lung Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 45 – 90
- Sex
- Any
- Study type
- Observational
- Participants needed
- 750 (estimated)
- Sponsor
- University of Colorado, Denver · Other
Who this trial is looking for
This trial is looking for people with rheumatoid arthritis who are 45 years or older. Participants will help researchers understand lung disease risk in people with rheumatoid arthritis.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 45 years old or older
- I have been diagnosed with rheumatoid arthritis
You may not be able to join if
- I cannot give informed consent
- I am pregnant
- I have a history of interstitial lung disease
- I have other causes of lung disease
- I am over 90 years old
- I am under 45 years old
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical RA-ILD, in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are common core elements (e.g. clinical features, genetic variants, and/or biologic markers) between other forms of ILD (e.g. idio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. ≥ 45years old
2. Diagnosis of RA using the 2010 American College of Rheumatology (ACR) criteria
Exclusion Criteria:
1. Inability to give informed consent
2. Pregnant women
3. History of interstitial lung disease
4. Evidence of other causes of diffuse parenchymal lung diseas…
Contacts